↓ Skip to main content

Dove Medical Press

Article Metrics

Worsened hypertension control induced by aripiprazole

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
21 Mendeley
Title
Worsened hypertension control induced by aripiprazole
Published in
Neuropsychiatric Disease and Treatment, April 2013
DOI 10.2147/ndt.s43950
Pubmed ID
Authors

Norio Yasui-Furukori, Akira Fujii

Abstract

Aripiprazole is widely used in the treatment of schizophrenia and bipolar disorders. Although antipsychotics generally have hypotensive effects, two cases were identified that demonstrated hypertension during the switch from other antipsychotics to aripiprazole. The hypertensive state of these patients recovered after switching back to other antipsychotics, and these cases suggest that aripiprazole may lead to hypertension.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 19%
Student > Ph. D. Student 4 19%
Researcher 3 14%
Student > Doctoral Student 2 10%
Librarian 2 10%
Other 3 14%
Unknown 3 14%
Readers by discipline Count As %
Medicine and Dentistry 5 24%
Psychology 4 19%
Computer Science 3 14%
Nursing and Health Professions 2 10%
Biochemistry, Genetics and Molecular Biology 1 5%
Other 3 14%
Unknown 3 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2018.
All research outputs
#17,686,611
of 22,707,247 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,051
of 2,973 outputs
Outputs of similar age
#145,222
of 200,162 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#26
of 49 outputs
Altmetric has tracked 22,707,247 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,973 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,162 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.